MedTrace Logo

COMPLETE: International Acute Ischemic Stroke Registry With the Penumbra System Aspiration Including the 3D Revascularization Device

NCT03464565 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 650

Last updated 2020-12-22

No results posted yet for this study

Summary

The purpose of this registry is to collect performance and safety data on the Penumbra System including the 3D Revascularization Device in a real world patient population with acute ischemic stroke (AIS) secondary to intracranial large vessel occlusion (LVO).

Conditions

  • Stroke, Ischemic

Interventions

DEVICE

Penumbra System

Penumbra System

Sponsors & Collaborators

  • Penumbra Inc.

    lead INDUSTRY

Principal Investigators

  • Osama O Zaidat, MD · Mercy St. Vincent Medical Center

  • Johanna Fifi, MD · Mount Sinai Health System

  • Ameer E. Hassan, MD · McAllen Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-02
Primary Completion
2020-01-17
Completion
2020-01-17
FDA Device
Yes

Countries

  • United States
  • France
  • Germany
  • Poland
  • Russia
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03464565 on ClinicalTrials.gov